U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07053176) titled 'Impact of Local Lidocaine Paravertebral Cervical Injection on Cervicogenic Dizziness Symptoms' on June 26.
Brief Summary: at least 42 patients affected by cervicogenic dizziness will be allocated to the experimental group or in the placebo group. in the first group patients will received 2 paravertebral intramuscular injection of lidocaine 0.5% while in the placebo group they will received saline solution with the same injection technique. patients will be evaluated by subjective and objective testing before the treatment, immediatly and 3 months after the treatment.
Study Start Date: Aug. 01
Study Type: INTERVENTIONAL
Condition: ...